%0 Journal Article
%T Development and promotion in translational medicine: perspectives from 2012 sino-american symposium on clinical and translational medicine
%A Mengjia Qian
%A Duojiao Wu
%A Ena Wang
%A Francesco M Marincola
%A Wei Wang
%A William Rhodes
%A Michael Liebman
%A Chunxue Bai
%A Ching-Wan Lam
%A Gyorgy Marko-Varga
%A Thomas E Fehniger
%A Roland Andersson
%A Xiangdong Wang
%J Clinical and Translational Medicine
%D 2012
%I Springer
%R 10.1186/2001-1326-1-25
%X This Session focused discussing on new models for project development and promotion in translational medicine. The conference stimulated the scientific and commercial communication of project development between academies and companies, shared the advanced knowledge and expertise of clinical applications, and created the environment for collaborations.Although strategic collaborations between corporate and academic institutions have resulted in a state of resurgence in the market, new cooperation models still need time to tell whether they will improve the translational medicine process.Clinical translational medicine (CTM) is an emerging area comprising multidisciplinary research from basic science to medical applications and entails a close collaboration among hospital, academia and industry [1]. CTM is to bridge the divide between health informatics ¡®bench research¡¯ and the application of informatics in clinical and health care settings [2]. The critical care community is beginning to adopt an increasingly translational approach to research, drug development and early-phase clinical trials [3].The 2012 Sino-American Symposium on Clinical and Translational Medicine (SAS-CTM) served as one of the milestone conferences on CTM and was organized by Chinese Academy of Engineering, Chinese Academy of Medical Sciences, The U.S. National Institutes of Health Clinical Center, and Global MD Organization. As a part of 2012 SAS-CTM, session seven, Project Development and Promotion in Translational Medicine, was co-chaired by Dr. Roland Anderson, Professor of Department of Surgery, Clinical Sciences,Medical Faculty, Lund University and Dr. Xiangdong Wang, Professor of Medicine and Director, Biomedical Research Center, Fudan University Zhongshan Hospital. The Session focused on new models for project development and promotion in translational medicine.Translational medicine is a growing and emerging area that integrates basic, social, clinical and political science together to
%U http://www.clintransmed.com/content/1/1/25